Global Stem Cell Umbilical Cord Blood Market Growth (Status and Outlook) 2023-2029

Global Stem Cell Umbilical Cord Blood Market Growth (Status and Outlook) 2023-2029

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

LPI (LP Information)' newest research report, the “Stem Cell Umbilical Cord Blood Industry Forecast” looks at past sales and reviews total world Stem Cell Umbilical Cord Blood sales in 2022, providing a comprehensive analysis by region and market sector of projected Stem Cell Umbilical Cord Blood sales for 2023 through 2029. With Stem Cell Umbilical Cord Blood sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stem Cell Umbilical Cord Blood industry.

This Insight Report provides a comprehensive analysis of the global Stem Cell Umbilical Cord Blood landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stem Cell Umbilical Cord Blood portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Stem Cell Umbilical Cord Blood market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stem Cell Umbilical Cord Blood and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stem Cell Umbilical Cord Blood.

The global Stem Cell Umbilical Cord Blood market size is projected to grow from US$ 18610 million in 2022 to US$ 131030 million in 2029; it is expected to grow at a CAGR of 32.2% from 2023 to 2029.

Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.

This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Umbilical Cord Blood market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Public Cord Blood Banks
Private Cord Blood Banks

Segmentation by application
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem

Please note: The report will take approximately 2 business days to prepare and deliver.